Annual report [Section 13 and 15(d), not S-K Item 405]

Revenues from Contracts and Significant Customers (Company's product revenue) (Details)

v3.25.1
Revenues from Contracts and Significant Customers (Company's product revenue) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Product revenue, net $ 55,134 $ 59,662
Other revenue 1,000 19,519
Net revenue 57,675 84,513
Related Party    
Revenue - related party 41 103
Other revenue 1,000 19,519
Qbrexza    
Product revenue, net 25,114 25,410
Accutane    
Product revenue, net 19,407 20,168
Amzeeq    
Product revenue, net 5,009 6,201
Zilxi    
Product revenue, net 1,643 1,962
Other / legacy product revenue    
Product revenue, net 3,961 5,921
Collaboration revenue    
Product revenue, net $ 1,500 5,229
Rapifort    
Other revenue   500
Rapifort | Journey    
Other revenue   $ 19,000